New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 13, 2012
07:23 EDTCYTKCytokinetics has potentially transformative catalysts, says JMP Securities
After attending Cytokinetics' R&D day, JMP Securities believes that the company has multiple value-inflecting and potentially transformative catalysts in 2013. The firm thinks the company may obtain a partner for its tirasemtiv treatment, and JMP Securities reiterates an Outperform rating on the shares.
News For CYTK From The Last 14 Days
Check below for free stories on CYTK the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 10, 2014
07:37 EDTCYTKCytokinetics announces additional results relating to Tirasemtiv
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use